Literature DB >> 32632817

Controversial: Early Innate Responses to Hepatitis B Virus Infection, an Explanation for Viral Persistence?

Ruth Broering1, Xufeng Luo2, Jia Liu3, Mengji Lu4.   

Abstract

Entities:  

Year:  2020        PMID： 32632817      PMCID： PMC7973328          DOI： 10.1007/s12250-020-00235-0

Source DB:  PubMed          Journal:  Virol Sin        ISSN： 1995-820X            Impact factor:   4.327


× No keyword cloud information.
  29 in total

1.  Long-term stimulation of Toll-like receptor 3 in primary human hepatocytes leads to sensitization for antiviral responses induced by poly I:C treatment.

Authors:  R Broering; M Lutterbeck; M Trippler; K Kleinehr; L Poggenpohl; A Paul; G Gerken; J F Schlaak
Journal:  J Viral Hepat       Date:  2013-10-06       Impact factor: 3.728

2.  Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells.

Authors:  Eva Billerbeck; Michiel C Mommersteeg; Amir Shlomai; Jing W Xiao; Linda Andrus; Ankit Bhatta; Koen Vercauteren; Eleftherios Michailidis; Marcus Dorner; Anuradha Krishnan; Michael R Charlton; Luis Chiriboga; Charles M Rice; Ype P de Jong
Journal:  J Hepatol       Date:  2016-05-02       Impact factor: 25.083

3.  Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.

Authors:  Marc Lütgehetmann; Lida V Mancke; Tassilo Volz; Martina Helbig; Lena Allweiss; Till Bornscheuer; Joerg M Pollok; Ansgar W Lohse; J Petersen; Stephan Urban; Maura Dandri
Journal:  Hepatology       Date:  2012-01-30       Impact factor: 17.425

4.  Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes.

Authors:  L G Guidotti; T Ishikawa; M V Hobbs; B Matzke; R Schreiber; F V Chisari
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

5.  Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.

Authors:  Xiaoyong Zhang; Zhiyong Ma; Hongyan Liu; Jia Liu; Zhongji Meng; Ruth Broering; Dongliang Yang; Joerg F Schlaak; Michael Roggendorf; Mengji Lu
Journal:  J Hepatol       Date:  2012-05-19       Impact factor: 25.083

6.  Different antiviral effects of IFNα and IFNβ in an HBV mouse model.

Authors:  Yun Zhou; Sheng Li; Zongsheng Tang; Chunli Xu; Shunmei Huang; Jun Wu; Ulf Dittmer; Julia Dickow; Kathrin Sutter; Mengji Lu; Dongliang Yang; Jingjiao Song
Journal:  Immunobiology       Date:  2016-11-08       Impact factor: 3.144

7.  Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.

Authors:  Masanori Isogawa; Michael D Robek; Yoshihiro Furuichi; Francis V Chisari
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

8.  Human hepatitis B virus surface and e antigens inhibit major vault protein signaling in interferon induction pathways.

Authors:  Shi Liu; Nanfang Peng; Jiajia Xie; Qian Hao; Mo Zhang; Yi Zhang; Zhangchuan Xia; Gang Xu; Fanpeng Zhao; Qing Wang; Tao Han; Ying Zhu
Journal:  J Hepatol       Date:  2014-12-03       Impact factor: 25.083

9.  Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection.

Authors:  Marianna Hösel; Maria Quasdorff; Katja Wiegmann; Dennis Webb; Uta Zedler; Mathias Broxtermann; Raindy Tedjokusumo; Knud Esser; Silke Arzberger; Carsten J Kirschning; Anja Langenkamp; Christine Falk; Hildegard Büning; Stefan Rose-John; Ulrike Protzer
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

10.  Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver.

Authors:  Mathilde Dusséaux; Guillemette Masse-Ranson; Sylvie Darche; James Ahodantin; Yan Li; Oriane Fiquet; Elodie Beaumont; Pierrick Moreau; Lise Rivière; Christine Neuveut; Patrick Soussan; Philippe Roingeard; Dina Kremsdorf; James P Di Santo; Helene Strick-Marchand
Journal:  Gastroenterology       Date:  2017-08-26       Impact factor: 22.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.